These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 33517686)

  • 1. miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology.
    Walsh AD; Nguyen LT; Binder MD
    ASN Neuro; 2021; 13():1759091420981182. PubMed ID: 33517686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial Phagocytosis-Rational but Challenging Therapeutic Target in Multiple Sclerosis.
    Pinto MV; Fernandes A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in microglia: deciphering their role in neurodegenerative diseases.
    Jadhav SP
    Front Cell Neurosci; 2024; 18():1391537. PubMed ID: 38812793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis.
    Nheu D; Ellen O; Ye S; Ozturk E; Pagnin M; Kertadjaja S; Theotokis P; Grigoriadis N; McLean C; Petratos S
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remyelination in multiple sclerosis from the miRNA perspective.
    Maciak K; Dziedzic A; Saluk J
    Front Mol Neurosci; 2023; 16():1199313. PubMed ID: 37333618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis.
    Jansen MI; Thomas Broome S; Castorina A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of MicroRNAs in Repair Processes in Multiple Sclerosis.
    Duffy CP; McCoy CE
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies.
    Karthikeyan A; Patnala R; Jadhav SP; Eng-Ang L; Dheen ST
    Curr Med Chem; 2016; 23(30):3528-3546. PubMed ID: 27528056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in Microglia: How do MicroRNAs Affect Activation, Inflammation, Polarization of Microglia and Mediate the Interaction Between Microglia and Glioma?
    Guo Y; Hong W; Wang X; Zhang P; Körner H; Tu J; Wei W
    Front Mol Neurosci; 2019; 12():125. PubMed ID: 31133802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis.
    Christoforidou E; Joilin G; Hafezparast M
    J Neuroinflammation; 2020 Apr; 17(1):135. PubMed ID: 32345319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia Diversity in Health and Multiple Sclerosis.
    Zia S; Rawji KS; Michaels NJ; Burr M; Kerr BJ; Healy LM; Plemel JR
    Front Immunol; 2020; 11():588021. PubMed ID: 33240276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination.
    Shen K; Reichelt M; Kyauk RV; Ngu H; Shen YA; Foreman O; Modrusan Z; Friedman BA; Sheng M; Yuen TJ
    Cell Rep; 2021 Mar; 34(10):108835. PubMed ID: 33691116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dicer deficiency in microglia leads to accelerated demyelination and failed remyelination.
    Tripathi A; Rai N; Perles A; Jones C; Dutta R
    bioRxiv; 2023 Oct; ():. PubMed ID: 37905110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial Phenotypes and Functions in Multiple Sclerosis.
    O'Loughlin E; Madore C; Lassmann H; Butovsky O
    Cold Spring Harb Perspect Med; 2018 Feb; 8(2):. PubMed ID: 29419406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia as therapeutic targets for central nervous system remyelination.
    Mahmood A; Miron VE
    Curr Opin Pharmacol; 2022 Apr; 63():102188. PubMed ID: 35219055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
    Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview.
    Piket E; Zheleznyakova GY; Kular L; Jagodic M
    J Autoimmun; 2019 Jul; 101():17-25. PubMed ID: 31014917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of microRNAs in microglia by real-time PCR in normal CNS and during neuroinflammation.
    Veremeyko T; Starossom SC; Weiner HL; Ponomarev ED
    J Vis Exp; 2012 Jul; (65):. PubMed ID: 22872097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs mediating CNS inflammation: Small regulators with powerful potential.
    Su W; Aloi MS; Garden GA
    Brain Behav Immun; 2016 Feb; 52():1-8. PubMed ID: 26148445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.